Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage
Authors:
- M.A. NooriMNM.A. Noori
- M. CiardiMCM. Ciardi
- A. CirelliACA. Cirelli
- E.J. ThompsonETE.J. Thompson
- 1 March 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 43 (1-2) , 15-21
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms.Journal of Clinical Investigation, 1992
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992
- ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).Journal of Cell Biology, 1990
- Leukocyte adhesion to endothelium in inflammationCell, 1990
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cellsNature, 1988
- Induction and detection of a human endothelial activation antigen in vivo.Journal of Experimental Medicine, 1986
- Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference valuesScandinavian Journal of Clinical and Laboratory Investigation, 1977
- XVIII.–The Histology of Disseminated SclerosisTransactions of the Royal Society of Edinburgh, 1916